![]() |
市場調查報告書
商品編碼
1904587
消化健康食品和益生菌快速消費品市場預測至2032年:按產品類型、分銷管道、技術和地區分類的全球分析Digestive Health Foods & Probiotic FMCG Market Forecasts to 2032 - Global Analysis By Product Type, Distribution Channel, Technology and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球消化健康食品和益生菌快速消費品市場價值將達到 560.9 億美元,到 2032 年將達到 980.2 億美元,在預測期內的複合年成長率為 8.3%。
消化健康食品和益生菌快速消費品旨在改善消化功能並維持健康的腸道菌叢。這些產品包括益生菌、發酵食品、益生元強化點心和機能飲料,它們都能促進有益腸道細菌的生長。健康意識的提高、消化問題發病率的增加以及人們對預防性健康解決方案的日益重視,正在推動市場成長。這些產品可透過超級市場、藥局和線上平台購買,吸引那些尋求天然、經科學驗證的方法來改善消化健康和整體健康的消費者。
胃腸道疾病呈上升趨勢
飲食習慣的改變、高壓力水平、久坐的生活方式以及加工食品消費量的增加,正在加劇全球範圍內的腸道相關問題。消費者越來越傾向於尋求預防性和日常營養的解決方案,而非只依賴治療方法。益生菌和消化健康食品被認為是恢復腸道菌叢平衡和改善整體消化功能的有效選擇。人們對腸腦軸和腸免疫軸之間聯繫的認知不斷提高,進一步推動了市場滲透。醫療保健專業人員也推薦益生菌作為維護消化健康的輔助。人們對消化健康的持續關注是成長要素。
缺乏全球標準化
益生菌、益生元和後生元的監管定義在不同地區差異顯著,為生產者帶來了合規的複雜性。菌株檢驗、劑量水平和健康聲明等方面的要求不一致,限制了產品的全球規模化生產。企業必須與包括FDA、EFSA和FSSAI在內的多個食品安全監管機構打交道,而每個機構都有各自的核准流程。由於研發能力有限,小規模公司往往難以滿足科學論證的要求。這種監管上的碎片化增加了產品上市時間和營運成本。因此,缺乏標準化阻礙了創新和跨境市場擴張。
非乳製品和植物來源創新
乳糖不耐症的日益普遍、素食生活方式的興起以及乳製品過敏的流行,正促使消費者尋求益生菌的替代來源。製造商們正不斷創新,推出植物來源產品,例如發酵果汁、穀物、豆類、康普茶和植物優格。這些產品吸引了注重健康和環保、追求「潔淨標示」解決方案的消費者。發酵技術的進步正在提高益生菌在非乳製品基質中的穩定性和功效。品牌正在利用超級食品和功能性植物成分來增強消化益處。這種向植物來源創新的轉變正在拓展消費群體,並促進產品差異化。
與製藥公司的競爭
由於處方藥和非處方藥能夠快速緩解症狀,因此是治療急性疾病的首選。對於嚴重的胃腸道疾病,醫療專業人員可能更傾向於使用經臨床驗證的藥物,而非機能性食品。胃腸道藥物的不斷進步正在鞏固藥品在治療領域的主導地位。許多地區的保險覆蓋範圍和報銷制度也更傾向於藥品,從而限制了膳食補充劑的滲透。這限制了益生菌食品在臨床胃腸道護理領域的普及。因此,來自藥品的競爭仍是市場成長的一大威脅。
新冠疫情加速了消費者對免疫力和腸道健康的關注,對消化健康食品和益生菌快速消費品市場產生了積極影響。封鎖措施提高了人們對腸道微生物群在整體健康和疾病抵抗力方面所起作用的認知。疫情期間,益生菌食品、補充品和強化飲料的需求激增。然而,供應鏈中斷最初影響了原料採購和產品分銷。隨著實體零售受到限制,電子商務和直接面對消費者的分銷管道變得日益重要。即使在疫情結束後,市場仍將繼續受益於預防性健康消費的持續趨勢。
預計在預測期內,益生菌食品和飲料領域將佔據最大的市場佔有率。
由於消費者廣泛接受,益生菌食品飲料領域預計將在預測期內佔據最大的市場佔有率。這些產品以優格、發酵飲料、功能性果汁、營養棒等形式融入日常飲食中。經常食用益生菌產品有助於維持腸道平衡、促進消化功能和增強免疫力,因此被視為預防措施。強大的品牌知名度和廣泛的零售分銷網路進一步推動了該領域的成長。口味、配方和功能方面的持續產品創新吸引了各個年齡層消費者的注意。食品級益生菌因其便利性和熟悉度而促進了重複購買。
預計在預測期內,後生元細分市場將呈現最高的複合年成長率。
由於科學證據的進步和產品穩定性優勢,預計在預測期內,後生元領域將實現最高成長率。與活性益生菌不同,後生元無需擔心儲存或保存期限問題,即可展現持續的功效。越來越多的研究強調了其抗發炎和免疫調節作用,這進一步激發了商業性的興趣。製造商正將後生元添加到機能性食品、飲料和膳食補充劑中。其非活性特性也使其更容易獲得監管部門的核准。消費者對傳統益生菌以外的先進腸道健康解決方案越來越感興趣。
預計北美地區將在預測期內佔據最大的市場佔有率,這主要得益於消費者對腸道健康和預防性營養的高度關注,從而為市場擴張提供了強勁動力。該地區擁有成熟的功能性食品和飲料產業,以及強大的研發能力。胃腸道疾病和文明病的增加正在推動產品的普及。機能性食品監管政策的明朗化也進一步促進了產品的上市。領先益生菌品牌的強大市場地位正在增強市場滲透率。
預計亞太地區在預測期內將實現最高的複合年成長率,快速的都市化和飲食習慣的改變正推動全部區域對消化健康的關注。中國、印度和東南亞等國家不斷壯大的中產階級人口正在推動功能性營養品的需求。傳統發酵食品與現代益生菌技術的融合正在促進市場接受度。人們預防保健意識的提高正在加速消化健康產品的消費。有組織的零售業態和電子商務平台的擴張正在提高產品的可及性。
According to Stratistics MRC, the Global Digestive Health Foods & Probiotic FMCG Market is accounted for $56.09 billion in 2025 and is expected to reach $98.02 billion by 2032 growing at a CAGR of 8.3% during the forecast period. Digestive Health Foods & Probiotic FMCG are consumer goods aimed at improving digestive function and supporting a healthy gut microbiome. They encompass items like probiotics, fermented foods, prebiotic-fortified snacks, and functional drinks that encourage the growth of beneficial intestinal bacteria. Rising health consciousness, the increasing occurrence of digestive issues, and a shift towards preventive wellness solutions fuel market growth. Accessible through supermarkets, pharmacies, and online platforms, these products appeal to individuals looking for natural, scientifically validated ways to enhance digestive health and overall well-being.
Rising gastrointestinal (GI) disorders
Changing dietary habits, high stress levels, sedentary lifestyles, and increased consumption of processed foods are worsening gut-related issues globally. Consumers are increasingly seeking preventive and daily nutrition-based solutions rather than relying solely on curative treatments. Probiotic and digestive health foods are perceived as effective options for restoring gut microbiome balance and improving overall digestive function. Greater awareness of the gut-brain and gut-immunity connection is further strengthening market adoption. Healthcare professionals are also recommending probiotics as complementary support for digestive wellness. This sustained rise in GI health concerns is acting as a major growth catalyst for the market.
Lack of global standardization
Regulatory definitions of probiotics, prebiotics, and postbiotics vary widely across regions, creating compliance complexity for manufacturers. Inconsistent requirements related to strain validation, dosage levels, and health claims limit global product scalability. Companies must navigate different food safety authorities, such as FDA, EFSA, and FSSAI, each with distinct approval processes. Smaller players often struggle to meet scientific substantiation requirements due to limited R&D capabilities. This regulatory fragmentation increases time-to-market and operational costs. As a result, lack of standardization restrains innovation and cross-border market expansion.
Non-dairy & plant-based innovation
Increasing lactose intolerance, vegan lifestyles, and dairy allergies are pushing consumers toward alternative probiotic sources. Manufacturers are innovating with plant-based formats such as fermented juices, cereals, legumes, kombucha, and plant-based yogurts. These products appeal to health-conscious and environmentally aware consumers seeking clean-label solutions. Advances in fermentation technology are improving the stability and efficacy of probiotics in non-dairy matrices. Brands are also leveraging superfoods and functional botanicals to enhance digestive benefits. This shift toward plant-based innovation is expanding consumer reach and product differentiation.
Competition from pharmaceuticals
Prescription drugs and over-the-counter medications often deliver faster symptomatic relief, making them a preferred option for acute conditions. Healthcare professionals may prioritize clinically proven pharmaceuticals over functional foods for severe digestive issues. Continuous advancements in gastroenterology drugs are strengthening pharmaceutical dominance in therapeutic segments. Insurance coverage and reimbursement further favor medicines over nutritional products in many regions. This limits the penetration of probiotic foods in clinical digestive care. Consequently, pharmaceutical competition remains a significant threat to market growth.
The COVID-19 pandemic positively influenced the digestive health foods and probiotic FMCG market by accelerating consumer focus on immunity and gut health. Lockdowns increased awareness of the role of the gut microbiome in overall wellness and disease resistance. Demand surged for probiotic foods, supplements, and fortified beverages during the pandemic period. However, supply chain disruptions affected raw material sourcing and product distribution initially. E-commerce and direct-to-consumer channels gained prominence as physical retail faced restrictions. Post-pandemic, the market continues to benefit from sustained preventive health consumption trends.
The probiotic foods & beverages segment is expected to be the largest during the forecast period
The probiotic foods & beverages segment is expected to account for the largest market share during the forecast period, due to widespread consumer acceptance. These products are integrated into daily diets through formats such as yogurts, fermented drinks, functional juices, and nutrition bars. Regular consumption supports gut balance, digestion, and immunity, making them a preferred preventive solution. Strong brand presence and extensive retail availability further enhance segment growth. Continuous product innovation in flavors, formulations, and functional benefits is attracting diverse age groups. The convenience and familiarity of food-based probiotics drive repeat purchases.
The postbiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the postbiotics segment is predicted to witness the highest growth rate, due to increasing scientific validation and product stability advantages. Unlike live probiotics, postbiotics offer consistent efficacy without concerns related to storage and shelf life. Growing research highlighting their anti-inflammatory and immune-modulating benefits is boosting commercial interest. Manufacturers are incorporating postbiotics into functional foods, beverages, and supplements. Regulatory acceptance is relatively easier due to their non-living nature. Consumers are becoming more aware of advanced gut-health solutions beyond traditional probiotics.
During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness regarding gut health and preventive nutrition strongly supports market expansion. The region has a well-established functional food and beverage industry with strong R&D capabilities. Rising prevalence of digestive disorders and lifestyle-related health issues is increasing product adoption. Regulatory clarity around functional foods further supports product launches. Strong presence of leading probiotic brands enhances market penetration.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization and changing dietary patterns are increasing digestive health concerns across the region. Growing middle-class populations in countries such as China, India, and Southeast Asia are driving demand for functional nutrition. Traditional fermented foods combined with modern probiotic innovations support market acceptance. Rising awareness of preventive healthcare is accelerating consumption of digestive health products. Expansion of organized retail and e-commerce platforms improves product accessibility.
Key players in the market
Some of the key players in Digestive Health Foods & Probiotic FMCG Market include Danone S., DSM-Firm, Nestle S.A, Lifeway Foods, Yakult Honsha, Abbott Laboratories, BioGaia AB, PepsiCo Inc., Probi AB, Cargill Inc., General Mills, GlaxoSmithKline, Arla Foods, Archer Daniels Midland, and Chr. Hansen.
In November 2025, dsm-firmenich announces the launch of The Art of Progress Prize, a new global art award celebrating a new generation of visionary artists. Based on the idea that art has the power to shift perspectives, challenge assumptions and spark fresh ideas, this initiative aims to recognize bold, early-career artists whose work brings together innovation, sensory experience, and the theme of sustainability to inspire progress.
In October 2025, Mars and Cargill, announced they are spurring the development of more than 224MWac* of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland. The PPAs were signed with GoldenPeaks Capital, one of Europe's fastest-growing independent producers of renewable energy. Two leading global food companies, Mars and Cargill, announced they are spurring the development of more than 224MWac of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.